Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/01/2009CA2757013A1 12-hour extended-release metoclopramide
10/01/2009CA2756800A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009CA2756731A1 Compositions and methods for diagnosing and treating melanoma
10/01/2009CA2756690A1 Administration of benzodiazepine compositions
10/01/2009CA2720800A1 Capsule for the prevention of cardiovascular diseases
10/01/2009CA2719853A1 Methods of treating fibrotic disorders
10/01/2009CA2719833A1 Compositions comprising anrnox-inhibitors for the inhibition of reactive oxygen species
10/01/2009CA2719830A1 Chewing gum compositions comprising cannabinoids
10/01/2009CA2719811A1 Fenofibrate dosage forms
10/01/2009CA2719803A1 Compositions and methods for the preparation of nanoemulsions
10/01/2009CA2719767A1 Inhibitors of antigen receptor-induced nf-.kappa.b activation
10/01/2009CA2719766A1 Method and compositions for treatment of cancer
10/01/2009CA2719751A1 Oral and injectable formulations of tetracycline compounds
10/01/2009CA2719745A1 Novel p2x7r antagonists and their use
10/01/2009CA2719743A1 Substituted cyclohexyldiamines
10/01/2009CA2719742A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009CA2719739A1 Hydroxymethylcyclohexylamines
10/01/2009CA2719736A1 Spiro(5.5)undecane derivatives
10/01/2009CA2719735A1 Substituted 4-aminocyclohexane derivatives
10/01/2009CA2719707A1 Therapy for vitiligo
10/01/2009CA2719624A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl) methyl-sulfamide
10/01/2009CA2719623A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications
10/01/2009CA2719605A1 Transdermally absorbable preparation
10/01/2009CA2719601A1 A composition for stabilizing .beta.-blocker and transdermally absorbable preparation comprising the same
10/01/2009CA2719560A1 An antimicrobial composition
10/01/2009CA2719555A1 Saponin extract from saponaria spp. and uses thereof
10/01/2009CA2719544A1 Novel substituted imidazoquinolines
10/01/2009CA2719477A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009CA2719453A1 Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics
10/01/2009CA2719412A1 Pyrido[3,4-b]indoles and methods of use
10/01/2009CA2719402A1 Process for preparation of benzo-fused heteroaryl derivatives
10/01/2009CA2719394A1 Hydroxyquinoxalinecarboxamide derivative
10/01/2009CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
10/01/2009CA2719256A1 Methods of treating epithelial injury
10/01/2009CA2719247A1 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
10/01/2009CA2719246A1 Stabilizing lipid compositions for oral pharmaceutical agents
10/01/2009CA2719243A1 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
10/01/2009CA2719226A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/01/2009CA2719202A1 Anti-tumor agent comprising cytidine derivative and carboplatin
10/01/2009CA2719164A1 Process for the preparation of donepezil hydrochloride
10/01/2009CA2718987A1 Method for crystallization of 2-amino-2-[2-[4-(3- benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride
10/01/2009CA2718983A1 Heterocyclic compounds as adenosine receptor antagonist
10/01/2009CA2718939A1 Novel solid forms of bendamustine hydrochloride
10/01/2009CA2718790A1 Bridged heterocyclic compounds and methods of use
10/01/2009CA2718755A1 Ketoprofen lysine salt-containing aqueous patch
10/01/2009CA2718727A1 Heterocyclic compound
10/01/2009CA2718653A1 Pharmaceutical composition 271
10/01/2009CA2718639A1 Methylphenidate extended release therapeutic drug delivery system
10/01/2009CA2718608A1 Solid forms of an anti-hiv phosphoindole compound
10/01/2009CA2718601A1 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
10/01/2009CA2718436A1 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator
10/01/2009CA2718412A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
10/01/2009CA2718411A1 Use and composition for treating dementia
10/01/2009CA2718209A1 (hetero)aryl cyclohexane derivatives
10/01/2009CA2718093A1 Ptph1 inhibitors for the treatment of alzheimer's disease
10/01/2009CA2717948A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
10/01/2009CA2717384A1 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
10/01/2009CA2717099A1 Compositions and methods for transmucosal delivery of lofexidin
10/01/2009CA2716961A1 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
10/01/2009CA2716932A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
10/01/2009CA2716726A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/01/2009CA2716642A1 Method for manufacturing acid pellets
10/01/2009CA2716088A1 Quinazolinone derivatives as tubulin polymerization inhibitors
10/01/2009CA2715151A1 Monocyclic cgrp receptor antagonists
10/01/2009CA2712613A1 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
10/01/2009CA2712468A1 Aminopiperidinyl derivatives and uses thereof
10/01/2009CA2711766A1 Process for preparing orally administered dabigatran formulations
09/2009
09/30/2009EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer
09/30/2009EP2105442A1 Method for producing c-glycoside derivative and synthetic intermediate thereof
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/30/2009EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009EP2105433A1 Modular scaffold for the design of specific molecules for the use as peptidomimetics and inhibitors of protein interaction
09/30/2009EP2105164A1 Novel P2X7R antagonists and their use
09/30/2009EP2105143A1 Pharmaceutical compositions based on salts of tiotropium and ciclesonide
09/30/2009EP2105137A1 A novel use of bivalirudin in the treatment of acute coronary syndrome
09/30/2009EP2105136A2 Pharmaceutical compositions for treating cancer
09/30/2009EP2105135A2 Pharmaceutical compositions for treating cancer
09/30/2009EP2105134A1 Stable amorphous fexofenadine hydrochloride
09/30/2009EP2105133A1 Intragastric floating-type levodopa sustained-release preparation
09/30/2009EP2105132A1 Use of an anti-atherothrombotic compound for the manufacture of medicaments for the treatment of vascular disorders
09/30/2009EP2105130A1 Pharmaceutical formula and method for its production
09/30/2009EP2105123A2 Skin care compositions containing a sugar amine and a vitamin B3 compound
09/30/2009EP2105055A1 Method for stimulating intestinal barrier integrity after birth by caesarean section
09/30/2009EP2105050A1 Method of controlling zoological and aquatic plant growth
09/30/2009EP2104738A2 Oligoribonucleotides and uses thereof
09/30/2009EP2104737A2 Functions and targets of let-7 micro rnas
09/30/2009EP2104736A2 Mir-126 regulated genes and pathways as targets for therapeutic intervention
09/30/2009EP2104680A2 Motilide polymorphs
09/30/2009EP2104677A1 Spiropiperidine glycinamide derivatives
09/30/2009EP2104673A2 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
09/30/2009EP2104672A2 2-(piperidin-4-yl0xy)pyrimidin-4-amine derivatives as deoxycytidine kinase inhibitors for the treatment of cancer
09/30/2009EP2104671A2 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
09/30/2009EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators
09/30/2009EP2104669A2 Inhibitors of akt activity
09/30/2009EP2104667A2 Synthesis of chromane derivatives in the presence of ionic liquids
09/30/2009EP2104666A1 THIAZOLE COMPOUND (AS PPARdelta) LIGAND AND PHARMACEUTICAL, COSMETIC AND HEALTH FOOD COMPRISED THEREOF
09/30/2009EP2104664A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein
09/30/2009EP2104535A1 Compounds and compositions as channel activating protease inhibitors
1 ... 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 ... 7860